NBE Therapeutics has continuously built relationships and established value-adding partnerships with groups at top-tier academic institutions, like ETH-Zurich, Switzerland, The Scripps Research Institute, U.S., the University Clinics Basel, Switzerland, and the University of Erlangen, Germany, to mention a few. Together with these selected academic partners the in-house developed capabilities of the company can optimally be leveraged for achieving the development goals of NBE-Therapeutics.
In addition, NBE-Therapeutics has also entered into value-adding strategic collaborations with industry-partners, like Sotio a.s., Czech Republic, part of the PPF Group, that has more than € 20 billion capital under management.
- Barcelona, 2017-05-18 - NBE-Therapeutics invited to present at the 2nd Annual Antibody Drug Conjugates (ADC) Summit: From Target to Therapeutics
- London, 2017-05-15 - NBE-Therapeutics will present at the 2nd Annual Advances in Immuno-Oncology Congress, London, U.K.
- Boston, MA, USA, 2017-05-02 - NBE-Therapeutics to present update on R&D activities at 2017-PEGS conference